“…Potential prognostic factors considered in the analysis were recipient age, disease risk, hematopoietic cell transplantation-specific comorbidity index, 20 HLA disparity in the GVH direction in HLA-A, -B, -C, -DRB1 alleles, donor type (related or unrelated), donor-recipient sex-match, conditioning regimen, SC source, GVHD prophylaxis, total number of hemophagocytic cells in BM clot sections on day þ 14 ± 7 and presence or absence of documented infections between day þ 7 and day þ 21. ES, sinusoidal obstruction syndrome, intestinal transplant-associated microangiopathy (intestinal TAM), 21,22 and posterior reversible encephalopathy syndrome were categorized as endothelial complications, as they are caused by vascular endothelial damage. 4,5,[21][22][23][24][25] P-values of less than 0.05 were considered statistically significant.…”